Quantum-si reports third quarter 2024 financial results

Branford, conn.--(business wire)--quantum-si incorporated (nasdaq: qsi) (“quantum-si,” “qsi” or the “company”), the protein sequencing company™, today announced financial results for the third quarter ended september 30, 2024. press release highlights reported revenue of $787,000 for the third quarter of 2024 announced that liberate bio has integrated platinum® next-generation sequencing into their platform for developing novel gene therapies with improved targeting capabilities announced appoi.
QMCO Ratings Summary
QMCO Quant Ranking